Bayesian Baskets: A Novel Design for Biomarker-Based Clinical Trials.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Clinical Oncology

• Publication date

  2017-01-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2016.68.2864PMID 28045624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review

  2016cited by this paper
• A Bayesian adaptive design for biomarker trials with linked treatments

  2015cited by this paper
• NCI-MATCH launch highlights new trial design in precision-medicine era.

  2015cited by this paper
• Lung Master Protocol (Lung-MAP)—A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400

  2015cited by this paper
• Marker Sequential Test (MaST) design

  2014cited by this paper
• Trial Designs for Personalizing Cancer Care: A Systematic Review and Classification

  2013cited by this paper
• Bayesian adaptive randomized trial design for patients with recurrent glioblastoma.

  2012cited by this paper
• Molecular prescreening to select patient population in early clinical trials

  2012cited by this paper
• Randomized phase II trial designs with biomarkers.

  2012cited by this paper
• Targeting population entering phase III trials: A new stratified adaptive phase II design

  2011cited by this paper
• How a new stratified adaptive phase II design could improve targeting population

  2011cited by this paper
• The BATTLE trial: personalizing therapy for lung cancer.

  2011cited by this paper
• A threshold sample-enrichment approach in a clinical trial with heterogeneous subpopulations

  2010cited by this paper
• Equipoise lost: ethics, costs, and the regulation of cancer clinical research.

  2010cited by this paper
• I‐SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy

  2009cited by this paper
• Speeding up the Evaluation of New Agents in Cancer

  2008cited by this paper
• Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset

  2007cited by this paper
• Pharmacogenomic Predictor Discovery in Phase II Clinical Trials for Breast Cancer

  2007cited by this paper
• An adaptive Simon Two-Stage Design for Phase 2 studies of targeted therapies.

  2007cited by this paper
• Adaptive Signature Design: An Adaptive Clinical Trial Design for Generating and Prospectively Testing A Gene Expression Signature for Sensitive Patients

  2005cited by this paper

• Harmonized Estimation of Subgroup-Specific Treatment Effects in Randomized Trials: The Use of External Control Data

  2023cites this paper
• Simulation study for evaluating an adaptive-randomisation Bayesian hybrid trial design with enrichment

  2023cites this paper
• Bayesian Sequential Design for Identifying and Ranking Effective Patient Subgroups in Precision Medicine in the Case of Counting Outcome Data with Inflated Zeros

  2023cites this paper
• Personalized Risk-Based Screening Design for Comparative Two-Arm Group Sequential Clinical Trials

  2022cites this paper
• Bayesian Basket Trial Design Accounting for Multiple Cutoffs of an Ambiguous Biomarker

  2022cites this paper
• Bayesian basket trial design with false-discovery rate control

  2022cites this paper
• Novel Clinical Trial Designs in Neuro-Oncology

  2022cites this paper
• Designing and conducting adaptive trials to evaluate interventions in health services and implementation research: practical considerations

  2022cites this paper
• Categories, components, and techniques in a modular construction of basket trials for application and further research

  2021influential citation
• Approximating the Operating Characteristics of Bayesian Uncertainty Directed Trial Designs.

  2021cites this paper
• Bayesian Hierarchical Modeling and Biomarker Cutoff Identification in Basket Trials

  2021influential citation
• Bayesian Cancer clinical trial designs with subgroup-specific decisions.

  2020cites this paper
• A Phase I-II Basket Trial Design to Optimize Dose-Schedule Regimes Based on Delayed Outcomes.

  2020cites this paper
• The Evolution of Master Protocol Clinical Trial Designs: A Systematic Literature Review.

  2020cites this paper
• Evidence‐Based Development and Clinical Use of Precision Oncology Therapeutics

  2020cites this paper
• Flexible Bayesian subgroup analysis in early and confirmatory trials.

  2020cites this paper
• BAGS: A Bayesian Adaptive Group Sequential Trial Design With Subgroup-Specific Survival Comparisons

  2020cites this paper
• Adaptive platform trials: definition, design, conduct and reporting considerations

  2019cites this paper
• Contrast enhancement on 100- and 120 kVp hepatic CT scans at thin adults in a retrospective cohort study

  2019cites this paper
• Basket Designs: Statistical Considerations for Oncology Trials.

  2019cites this paper
• Divining Responder Populations from Survival Data.

  2019cites this paper
• Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma

  2019cites this paper
• Bayesian adaptive basket trial design using model averaging.

  2019cites this paper
• Precision Medicine Is Not Just Genomics: The Right Dose for Every Patient.

  2018cites this paper
• Platform trials arrive on time for glioblastoma.

  2018cites this paper
• The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?

  2018cites this paper
• Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology

  2018cites this paper
• Variance prior specification for a basket trial design using Bayesian hierarchical modeling

  2018cites this paper
• Bayesian hierarchical classification and information sharing for clinical trials with subgroups and binary outcomes

  2018cites this paper
• How to Design Phase I Trials in Oncology

  2018cites this paper
• Methods and Biostatistics in Oncology

  2018cites this paper
• Primary brain tumours in adults.

  2018cites this paper
• The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncology

  2018cites this paper
• New designs for basket clinical trials in oncology

  2018cites this paper
• Bayesian Uncertainty Directed Trial Designs

  2018cites this paper
• Combining Bayesian experimental designs and frequentist data analyses: motivations and examples

  2017cites this paper
• Optimizing drug development in oncology by clinical trial simulation: Why and how?

  2017cites this paper